Skip to main content
. Author manuscript; available in PMC: 2019 May 30.
Published in final edited form as: EuroIntervention. 2018 May 20;14(1):121–128. doi: 10.4244/EIJ-D-18-00112

Table 1 –

Baseline characteristics

Parameter All patients Controlled
Hypertensi
Uncontro
Hypertension
p-value*
Value N Value N Value N
Male (%) 573 (57%) 985 74 (60%) 123 489 (57%) 862 0.472
Age, years 63.8±10.8 985 62.4±10.5 123 63.9±10.8 862 0.137
BMI, kg/m2 30.4±5.4 985 30.8±5.1 123 30.3±5.4 862 0.353
Type 2 diabetes (%) 372 (38%) 985 42 (34%) 123 330 (38%) 862 0.353
CAD (%) 269 (27%) 985 30 (24%) 123 239 (28%) 862 0.374
GFR, ml/(min*1.73m2) 75.9±29.1 875 76.8±34.6 118 75.7±28.1 757 0.863
Number of antihypertensive dugs 4.8±1.6 985 5.0±1.6 123 4.8±1.7 862 0.452
SBP, mmHg 167.9±25.9 985 130.6±8.5 123 173.2±23.1 862 <0.001
DBP, mmHg 89.9±17.1 985 75.2±10.7 123 91.9±16.8 862 <0.001
PP, mmHg 78.0±20.7 985 55.4±10.2 123 81.3±19.7 862 <0.001
Heart rate, bpm 66.9±11.6 985 66.5±11.8 123 66.9±11.6 862 0.499

Values are means ± SD or numbers (%).

*

p-values for comparison of controlled and uncontrolled hypertension (based upon ESH/ESC guidelines, 2013).

BMI = body mass index (kg/m2); CAD = coronary artery disease; DBP = diastolic office blood pressure; GFR = glomerular filtration rate; HR = heart rate; PP = pulse pressure; SBP = systolic office blood pressure.